Home » Newsletters » BioWorld Science

BioWorld Science

April 26, 2012

View Archived Issues

Scientists at Merck & Co. present novel phosphodiesterase 10A inhibitors

Pfizer patents novel acetyl-CoA carboxylase inhibitors

New data disclosed on first PI3Kalpha-specific anticancer agent to enter clinic

New candidate cancer drugs discovered at Bristol-Myers Squibb

New insulin secretagogues designed in Japan

Pathway Therapeutics discloses novel PI3K/mTOR inhibitors

Lucassin approved in Australia

Chinese study yields potential biomarker of PAH severity due to heart disease

Novel data presented on launched antiepileptic at ongoing AAN meeting

Troponin activator shows promise in patients with ALS

Astellas and Drais enter partnership for candidate ulcerative colitis drug

Compugen validates two new products in autoimmune disease models

Dainippon Sumitomo Pharma completes acquisition

FDA extends review date for Relistor sNDA

Watson Pharmaceuticals announces plan for strategic acquisition

Takeda receives complete response letter for alogliptin product NDAs

Kythera Biopharmaceuticals reports on European ATX-101 studies

Eisai reports launch of Halaven in Canada

Reimbursement allows early availability of Scenesse in Switzerland

Abbott research results in new potential analgesics

New phase III data support use of levomilnacipran for MDD

Dosing complete in phase IIb blisibimod study

New Ranbaxy combination drug for malaria launched first in India

Boston Scientific stent system set for launch in Canada

First-in-human data confirm safety of Repligen product for spinal muscular atrophy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...